S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4721 Reports
🤖 AI Analyzed
Recent
📄 Page 77 of 394
Monopar Therapeutics
10-K March 27, 2026

Key Highlights

  • Advancing clinical-stage pipeline including MNPR-101 for advanced cancers and AL...
  • Established internal research capabilities with a new 10,000-square-foot laborat...
  • Secured a strategic licensing agreement with TacticPharma for the development of...
Read Analysis
🤖 AI Generated
Kezar Life Sciences, Inc.
10-K March 27, 2026

Key Highlights

  • Exploring strategic alternatives including potential sale, merger, or licensing
  • Cash runway extended into 2027 with $109.5 million in reserves
  • Focus on high-potential clinical trials like the PORTOLA study
Read Analysis
🤖 AI Generated
BayFirst Financial Corp.
10-K March 27, 2026

Key Highlights

  • Strategic pivot to focus exclusively on local community banking in Florida.
  • Exited nationwide residential mortgage and SBA 7(a) lending divisions to reduce ...
  • Leveraging local market expertise to build loyalty and improve operational effic...
Read Analysis
🤖 AI Generated
Phunware, Inc.
10-K March 27, 2026

Key Highlights

  • Strategic pivot from mobile app building to specialized Agentic AI solutions.
  • Streamlining operations by discontinuing the legacy 'App Creator' service.
  • Focus on high-growth AI concierge and automated support sectors.
Read Analysis
🤖 AI Generated
BioCrude Technologies USA, Inc.
10-K March 27, 2026

Key Highlights

  • Innovative waste-to-energy model targeting city trash for renewable energy and f...
  • Potential to capture value from avoided carbon taxes and environmental cleanup c...
  • Strategic focus on long-term contracts with municipalities to secure waste suppl...
Read Analysis
🤖 AI Generated
HYDROFARM HOLDINGS GROUP, INC.
10-K March 27, 2026

Key Highlights

  • Focus on 33 proprietary brands offering 5-10% higher profit margins.
  • Strategic pivot toward food and floral markets to reduce cannabis industry relia...
  • Active restructuring plan targeting $15 million in annual cost savings.
Read Analysis
🤖 AI Generated
Bit Digital, Inc
10-K March 27, 2026

Key Highlights

  • Strategic pivot from Bitcoin mining to high-yield Ethereum staking and AI infras...
  • Secured 4,096 high-end NVIDIA GPUs to power a growing AI and cloud computing bus...
  • Strong liquidity position with $118 million in cash to fund infrastructure witho...
Read Analysis
🤖 AI Generated
Hoth Therapeutics, Inc.
10-K March 27, 2026

Key Highlights

  • Diverse pipeline targeting high-growth areas including Alzheimer’s, dermatology,...
  • Expansion of HT-001 clinical trials into the European market.
  • Strategic pivot into the weight-loss drug sector to capture investor interest.
Read Analysis
🤖 AI Generated
BioXcel Therapeutics, Inc.
10-K March 27, 2026

Key Highlights

  • Utilizes proprietary 'PharmDex' AI platform to repurpose FDA-approved drugs, acc...
  • Commercialized IGALMI® for agitation in schizophrenia and bipolar disorder.
  • Advancing clinical pipeline with BXCL501 for Alzheimer’s-related agitation and B...
Read Analysis
🤖 AI Generated
Bio Essence Corp
10-K March 27, 2026

Key Highlights

  • Revenue surged 485% YoY due to a successful pivot to a service-based model.
  • Operating expenses were reduced by 60% by eliminating factory ownership.
  • Achieved a $895,000 profit in 2025, recovering from a $1,520,000 loss in 2024.
Read Analysis
🤖 AI Generated
PermRock Royalty Trust
10-K March 27, 2026

Key Highlights

  • Provides direct monthly income distributions from 3,900 acres in the Permian Bas...
  • High-yield pass-through structure with no debt and no cash reserves
  • 80% net profit interest in oil and gas production
Read Analysis
🤖 AI Generated
Synchrony Card Funding, LLC
10-K March 27, 2026

Key Highlights

  • Successfully issued $3.1 billion in new asset-backed securities throughout 2025 ...
  • Maintains a robust 'AAA' investment-grade rating supported by a 15-20% cash cush...
  • Demonstrates consistent market demand with note issuances ranging from $750 mill...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage